Search

everythinglearnresearchcommunity

for

Search:↓

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

More men are using medication for benign prostatic hyperplasia, influenced by marketing and FDA approvals.

Ranitidine and finasteride lower TMAO levels, reducing heart and kidney damage by changing gut bacteria.

Restolin Hair Supplement may help hair growth but lacks FDA approval and clinical trial evidence.

Non-daily Dutasteride is more cost-effective and has lower cancer incidence than daily treatment.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Finasteride use for hair loss is linked to an increased risk of suicidal thoughts and a higher risk of suicide.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Finasteride reduces PSA levels by around 40-50% in BPH patients.

HDAC inhibitors like Vorinostat and Entinostat may encourage hair regrowth and could be new treatments for hair loss conditions.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

The new baby shampoo and wash with stearic acid is safe and potentially effective for nourishing babies' skin.

Finasteride use may increase depression and suicide risk, especially at 1 mg, so monitoring is advised.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

St. John's wort increases finasteride metabolism, reducing its effectiveness; use caution when combining them.

SCD1 inhibitors can cause skin issues in rodents.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

The drug combination was safe and showed promise in treating advanced tumors.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Dutasteride may help reduce brain inflammation and improve cognition.

Oral finasteride may cause more sexual side effects than expected, possibly due to negative publicity and reporting bias.

Finasteride and dutasteride have little effect on Type 2 Diabetes risk.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Strontium ranelate is no longer available for treatment.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.